Key Takeaways & Executive Findings
- •• Bone marrow-derived macrophages from C57BL/6 mice were successfully isolated and cultured, with F4/80 positivity reaching 98.1% after 7 days of M-CSF stimulation. • Lipopolysaccharide (100 ng/mL) for 6 hours effectively induced M1 polarization, characterized by increased CD86 expression and upregulation of iNOS, IL-6, MIP-1α, and MCP-1 mRNA. • Interleukin-4 (20 ng/mL) for 24 hours effectively induced M2 polarization, characterized by increased CD206 expression and upregulation of Ym1, IL-10, and Arg-1 mRNA. • Western blot confirmed activation of p-STAT1 in M1 and p-STAT6 in M2, validating the signaling pathways involved in polarization. • The established protocol provides a standardized in vitro model for studying macrophage polarization mechanisms and potential therapeutic applications.
Abstract
BACKGROUND: Macrophage polarization demonstrates significant potential in disease treatment, particularly in areas such as cancer, inflammation, and autoimmune diseases. Establishing standardized in vitro models can lay the groundwork for in-depth research into the mechanisms of macrophage polarization. OBJECTIVE: To observe the in vitro growth characteristics of bone marrow-derived macrophages from C57BL/6 mice and to establish a standardized in vitro model for M1 and M2 macrophage polarization. METHODS: Femurs and tibias of C57BL/6 mice were aseptically separated, and the contents of the bone marrow cavity were collected. After filtering through a mesh and lysing erythrocytes, the contents were resuspended in high-glucose DMEM containing 20 ng/mL macrophage colony-stimulating factor and inoculated in 6-well plates according to experimental requirements. On day 7, they were differentiated into mature mouse bone marrow-derived macrophages (M0 type). Then, 100 ng/mL lipopolysaccharide was used to induce polarization to M1 type, and 20 ng/mL interleukin-4 was used to induce polarization to M2 type. Flow cytometry and RT-qPCR were used to detect the expression of corresponding markers in macrophages under different polarization states, and Western blot was used to detect the expression of M1 macrophage marker pathway proteins p-STAT1, STAT1 and M2 macrophage marker pathway proteins p-STAT6, STAT6. RESULTS AND CONCLUSION: (1) After stimulation with 20 ng/mL macrophage colony-stimulating factor for 7 days, flow cytometry showed that the positive rate of macrophage surface marker F4/80 reached 98.1%. (2) After stimulation with 100 ng/mL lipopolysaccharide for 6 h, the positive rates of F4/80 and CD86 were about 35%, and RT-qPCR showed that the mRNA expression of M1 macrophage markers inducible nitric oxide synthase, interleukin-6, macrophage inflammatory protein 1α, and monocyte chemoattractant protein 1 were significantly higher than those in the control group (P < 0.01). (3) After stimulation with 20 ng/mL interleukin-4 for 24 h, the mean fluorescence intensity of CD206 was significantly increased, and RT-qPCR showed that the mRNA expression of M2 macrophage markers Chi3l3 (Ym1), interleukin-10, and arginase 1 were significantly higher than those in the control group (P < 0.01). (4) Western blot results showed that lipopolysaccharide-induced M1 macrophage marker pathway protein p-STAT1 was significantly activated; interleukin-4-induced M2 macrophage marker pathway protein p-STAT6 was significantly activated. These results indicate that lipopolysaccharide and interleukin-4 effectively induced polarization of bone marrow-derived macrophages to M1 and M2 types, respectively.
1. Introduction
Macrophages are key cells in the human immune system and play an important role in disease pathogenesis and inflammatory microenvironment formation [1]. Macrophage polarization refers to the process by which macrophages change their phenotype according to microenvironmental changes, thereby exerting multiple functions, also known as macrophage phenotype switching or reprogramming. Generally, macrophage polarization induced by microenvironmental changes is highly heterogeneous and plastic, and can be divided into classically activated macrophages (M1) and alternatively activated macrophages (M2) [2-3]. The induction of M1 macrophages mainly depends on the combined action of Th1 cytokines interferon-γ and/or lipopolysaccharide. When pathogens invade the body, macrophages, as the main effector cells for eliminating pathogens, polarize to M1 type, recognize antigens, and release a large number of pro-inflammatory mediators (such as interleukin-1, interleukin-6, tumor necrosis factor-α, inducible nitric oxide synthase) and chemokines (such as chemokine 2-4 and chemokine 8-11) [4-5], thereby producing reactive oxygen species and reactive nitrogen species, and enhancing the expression of surface markers such as MHC-I/II, CD80, CD86, exerting pro-inflammatory effects [6-7]. The induction of M2 macrophages depends on the action of Th2 cytokines interleukin-4 and/or interleukin-13. M2 macrophages include three subgroups: M2a, M2b, and M2c, which can respond specifically to different stimuli. M2a macrophages are induced by interleukin-4 and interleukin-13, M2b macrophages are induced by interleukin-1β, and M2c macrophages are induced by glucocorticoids, interleukin-10, and transforming growth factor-β. All three subtypes highly express anti-inflammatory factors and participate in tissue repair and immune regulation.
Loading authentic research manuscript (Pages 1–5)...
Tan Yuhang, Li Bo, Tang Minghong, Sun Zeyu, Luo Xu (2026). Isolation, cultivation, identification, and induction of M1/M2 polarization in bone marrow-derived macrophages from C57BL/6 mice. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21205
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the optimal concentration and duration of lipopolysaccharide (LPS) for inducing M1 polarization in bone marrow-derived macrophages?
In this study, 100 ng/mL LPS for 6 hours effectively induced M1 polarization, as evidenced by increased CD86 expression and upregulation of M1 markers (iNOS, IL-6, MIP-1α, MCP-1) at mRNA level, and activation of p-STAT1.
How is M2 polarization induced in bone marrow-derived macrophages?
M2 polarization was induced by treating bone marrow-derived macrophages with 20 ng/mL interleukin-4 (IL-4) for 24 hours, leading to increased CD206 expression and upregulation of M2 markers (Ym1, IL-10, Arg-1) at mRNA level, and activation of p-STAT6.
What are the key markers used to identify M1 and M2 macrophages in this study?
For M1 macrophages, markers include CD86, iNOS, IL-6, MIP-1α, and MCP-1. For M2 macrophages, markers include CD206, Ym1, IL-10, and Arg-1. Additionally, signaling proteins p-STAT1 (M1) and p-STAT6 (M2) were assessed by Western blot.
What is the purity of bone marrow-derived macrophages after 7 days of differentiation?
After 7 days of culture with 20 ng/mL macrophage colony-stimulating factor, flow cytometry showed that the positive rate of F4/80, a macrophage surface marker, reached 98.1%, indicating high purity.
Why is it important to establish a standardized in vitro model for macrophage polarization?
A standardized in vitro model allows for reproducible and controlled studies of macrophage polarization mechanisms, facilitating research in cancer, inflammation, and autoimmune diseases, and aiding in the development of therapeutic strategies targeting macrophage polarization.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.